Stefano Navarro

7PUBLICATIONS
33CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyGlycoconjugatesCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 01, 2026
Partial downregulation of platelet glycoprotein VI by low affinity antibodies confers sustained and safe antithrombotic protection.

|Jan 22, 2026
Platelet-derived integrin- and tetraspanin-enriched tethers exacerbate severe inflammation.

Charly Kusch, David Stegner, Lukas J Weiss

|Apr 02, 2025
EMA601 and glenzocimab: two glycoprotein VI inhibitory Fabs with different potency.

Bernhard Nieswandt, David Stegner, Stefano Navarro

|Aug 16, 2024
The humanized platelet glycoprotein VI Fab inhibitor EMA601 protects from arterial thrombosis and ischaemic stroke in mice.

Stefano Navarro, Ivan Talucci, Vanessa Göb

|Aug 31, 2022
Antibody-mediated depletion of human CLEC-2 in a novel humanized mouse model.

Helena C Brown, Sarah Beck, Stefano Navarro

|Aug 12, 2022
Targeting of a Conserved Epitope in Mouse and Human GPVI Differently Affects Receptor Function.

Stefano Navarro, Andreas Starke, Johan W M Heemskerk

Pageof 2

Frequent Collaborators

5 joint publications

David Stegner

4 joint publications

Bernhard Nieswandt

2 joint publications

Johan W M Heemskerk

2 joint publications

Marijke J E Kuijpers